Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R. Cervera, R.A. Asherson.
Síndrome antifosfolipídico: nuevas perspectives clínicas y terapéuticas.
Reumatol Clin, 1 (2005), pp. 183-186
[2.]
M.H. Rosove, P.M.C. Brewer.
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Ann Intern Med, 117 (1992), pp. 303-308
[3.]
M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, G.R.V. Hughes.
The management of thrombosis in the antiphospholipid-antibody syndrome.
N Engl J Med, 332 (1995), pp. 993-997
[4.]
S. Krnic-Barrie, C.R. O’Connor, S.W. Looney, S.S. Pierangeli, E.N. Harris.
A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
Arch Intern Med, 157 (1997), pp. 2101-2108
[5.]
G. Ruiz-Irastorza, M.A. Khamashta, B.J. Hunt, A. Escudero, M.J. Cuadrado, G.R.V. Hughes.
Bleeding and recurrent thrombosis in definite antip hospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target INR of 3.5.
Arch Intern Med, 162 (2002), pp. 1164-1169
[6.]
S. Schulman, E. Svenungsson, Granqvist S and the Duration of Anticoagu lation Study Group.
Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy.
Am J Med, 104 (1998), pp. 332-338
[7.]
C. Kearon, M. Gent, J. Hirsh, J. Weitz, M.J. Kovacs, D.R. Anderson, et al.
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
N Engl J Med, 340 (1999), pp. 901-907
[8.]
M.A. Crowther, J.S. Ginsberg, J. Julian, J. Denburg, J. Hirsh, J. Douketis, et al.
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome.
N Engl J Med, 349 (2003), pp. 1133-1138
[9.]
S.R. Levine, R.L. Brey, B.C. Tilley, J.L. Thompson, R.L. Sacco, R.R. Sciacca, et al.
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Jama, 291 (2004), pp. 576-584
[10.]
G. Ruiz-Irastorza, M.A. Khamashta.
Stroke and antiphospholipid syndrome: the treatment debate.
Rheumatology (Oxford), 44 (2005), pp. 971-974
Copyright © 2007. Elsevier España S.L Barcelona
